Impact News +++ Uranium Energy drops after short report from Spruce Point Capital (SeekingAlpha) +++ URANIUM ENERGY Aktie -3,67%

ELANCO Aktie

>ELANCO Aktienkurs

15.962 EUR (Tradegate)

Ask: 16.006 EUR / 1250 Stück

Bid: 15.918 EUR / 1260 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ELANCO Aktie über LYNX handeln

Intraday

1 Jahr

>ELANCO Performance

1 Woche: -3,3%

1 Monat: +2,0%

3 Monate: +30,0%

6 Monate: +62,5%

1 Jahr: +21,3%

laufendes Jahr: +35,1%

>ELANCO Aktie

Name:

ELANCO ANIMAL HEALTH.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US28414H1032 / A2N6BH

Symbol/ Ticker:

5EA (Frankfurt) / ELAN (NYSE)

Kürzel:

FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN

Index:

Webseite:

https://www.elanco.com/

Profil:

Elanco Animal Health Incorporated is a leading glo..
>Volltext..

Marktkapitalisierung:

7810.5 Mio. EUR

Unternehmenswert:

10928.91 Mio. EUR

Umsatz:

3783.89 Mio. EUR

EBITDA:

736.69 Mio. EUR

Nettogewinn:

366.24 Mio. EUR

Gewinn je Aktie:

0.74 EUR

Schulden:

3551.82 Mio. EUR

Liquide Mittel:

454.84 Mio. EUR

Operativer Cashflow:

482.69 Mio. EUR

Bargeldquote:

0.39

Umsatzwachstum:

-9.23%

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ELANCO

Letzte Datenerhebung:

18.09.25

>ELANCO Kennzahlen

Aktien/ Unternehmen:

Aktien: 496.81 Mio. St.

Frei handelbar: 99.05%

Leerverk. Aktien: 5.22%

Rückkaufquote: -

Mitarbeiter: 9450

Umsatz/Mitarb.: 0.4 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 2.59%

Bewertung:

KGV: 21.07

KGV lG: 20.94

KUV: 2.08

KBV: 1.35

PEG-Ratio: -

EV/EBITDA: 14.84

Rentabilität:

Bruttomarge: 42.98%

Gewinnmarge: 9.68%

Operative Marge: 4.66%

Managementeffizenz:

Gesamtkaprendite: 3.16%

Eigenkaprendite: 6.83%

>ELANCO Peer Group

Es sind 601 Aktien bekannt.

>ELANCO Chart & Kurs - NYSE

>ELANCO News

17.09.25 - 20:06	HSLDA Members Sue ELANCO School District for Allegedly Unlawful Harassment of Homeschool Families (PR Newswire)
	LANCASTER COUNTY, Pa., Sept. 17, 2025 /PRNewswire-PRWeb/ -- Two homeschool families have filed suit against the Eastern Lancaster County (ELANCO) School District after officials allegedly threatened them with criminal prosecution unless they produced copies of their high school......

09.09.25 - 20:06

Anglo American buys Canada′s Teck in Big Mining Deal | Open Interest 9/9/2025 (Bloomberg)

Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Anglo American buys Canada's Teck, creating a more than $50 billion company -- in one of the biggest mining deals in over a decade. Meanwhile, Apple is set to unveil its first major new iPhone design in several years. Murdoch's $3.3B succession deal hands Lachlan control of the empire. And the CEO of the Pet Heath Company Elanco joins Bloomberg Open Interest to talk about its latest developments in pet care drugs. (Source: Bloomberg)...

09.09.25 - 18:12	Elanco CEO Says Blockbuster Drugs Driving Business (Bloomberg)
	Jeff Simmons, Elanco CEO, says the willingness to spend on a pet is the highest it's ever been, and this strong tailwind in the industry is driving the growth of innovative drugs for Elanco. (Source: Bloomberg)...

08.09.25 - 18:42	Elanco Innovation Builds Momentum, Credelio Quattro Reaches Blockbuster Status (Accesswire)
	Credelio Quattro marked $100 million in net sales making it Elanco's fastest pet health blockbuster in history and one of the industry's fastest ever, especially with a single geographic approvalCr......

08.09.25 - 12:30	Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status (PR Newswire)
	Credelio Quattro marked $100 million in net sales making it Elanco's fastest pet health blockbuster in history and one of the industry's fastest ever, especially with a single geographic approval Credelio Quattro joins Experior® as Elanco's second of six recently launched......

27.08.25 - 14:03	Splenda® Joins Elanco and HATCH to Support ′Nutrition Secure Indianapolis′ to Strengthen Family Health Through Nutrition and Education (PR Newswire)
	Coalition of community leaders creates new initiative that delivers weekly nutritious food, sugar reduction tools, and wellness education to 250 families across Indianapolis CARMEL, Ind., Aug. 27, 2025 /PRNewswire/ -- Splenda®, a leading global health and wellness brand in sweeteners, has......

27.08.25 - 07:21	Elanco Animal Health set to join S&P MidCap 400, Sarepta to join S&P SmallCap 600 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.08.25 - 00:18	Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600 (PR Newswire)
	NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE: ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp Inc. (NASD: BRKL) in the S&P SmallCap 600 effective prior to the opening of......

26.08.25 - 14:06	Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
	GREENFIELD, Ind., Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 23rd Annual Global Healthcare Conference, September 8-9, 2025. Jeff Simmons, President and CEO, and Bob VanHimbergen, Executive Vice President and CFO, will......

15.08.25 - 21:06	Elanco CEO Jeff Simmons: Innovation and Sustainability Drive Long-Term Growth (Accesswire)
	NORTHAMPTON, MA / ACCESS Newswire / August 15, 2025 / Jeff Simmons, President and CEO of Elanco Animal Health, recently joined the Bloomberg Businessweek Daily to discuss the company's strategic fr......

08.08.25 - 02:00	Elanco raises 2025 innovation revenue outlook to $720M–$800M, signals margin expansion through new launches (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 22:06

Trump′s Team Impressed with Waller for Fed Chair | Bloomberg Businessweek Daily 8/7/2025 (Bloomberg)

On today's episode of Bloomberg Businessweek Daily, Carol Massar and Norah Mulinda look into Trump's latest calls for Intel's new CEO to resign. They also discussed Waller's emergence as favorite for Fed Chair among Trump's Team. Jeff Simmons, President and CEO of Elanco Animal Health also joined to discuss the company's quarterly earnings and the future of pet and animal health. (Source: Bloomberg)...

07.08.25 - 19:30	Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook (Benzinga)
	Elanco beats Q2 expectations and raises 2025 guidance as strong Pet Health sales and FX tailwinds offset tariff and investment impacts. read more...

07.08.25 - 15:15	Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates (Zacks)
	Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +30.00% and +4.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.08.25 - 14:15	Elanco spikes after Q2 beat, guidance raise (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 13:48	Elanco (ELAN) Q2 Revenue Jumps 5% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 13:24	Elanco Animal Health Raises 2025 Guidance (AFX)
	WASHINGTON (dpa-AFX) - Elanco Animal Health Incorporated (ELAN) said, for fiscal 2025, the company now expects adjusted earnings per share in $0.85 to $0.91, revised from prior guidance range of $......

07.08.25 - 12:33	Elanco Non-GAAP EPS of $0.26 beats by $0.06, revenue of $1.24B beats by $50M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 12:30	Elanco Animal Health Reports Second Quarter 2025 Results (PR Newswire)
	Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2025 Financial Results: Revenue of $1,241 million, an increase of 5% year-over-year; 8% organic constant currency growth Reported Net Income of $11 million, Adjusted Net Income of......

24.07.25 - 23:45	Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs (PR Newswire)
	The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market before the end of Q3 2025 GREENFIELD, Ind., July 24, 2025 /PRNewswire/ -- Elanco Animal......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wille - auf den kommt alles an, er kann zum Gott uns adeln und zum Tier entwürdigen. - Zacharias Werner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram